209 related articles for article (PubMed ID: 26158413)
1. TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney.
Gooskens SL; Gadd S; Guidry Auvil JM; Gerhard DS; Khan J; Patidar R; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Mullighan CG; Ma J; Jennings LJ; de Krijger RR; van den Heuvel-Eibrink MM; Smith MA; Ross N; Gastier-Foster JM; Perlman EJ
Oncotarget; 2015 Jun; 6(18):15828-41. PubMed ID: 26158413
[TBL] [Abstract][Full Text] [Related]
2. TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.
Gooskens SL; Klasson TD; Gremmels H; Logister I; Pieters R; Perlman EJ; Giles RH; van den Heuvel-Eibrink MM
Mol Oncol; 2018 Feb; 12(2):166-179. PubMed ID: 29080283
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A.
Arab K; Park YJ; Lindroth AM; Schäfer A; Oakes C; Weichenhan D; Lukanova A; Lundin E; Risch A; Meister M; Dienemann H; Dyckhoff G; Herold-Mende C; Grummt I; Niehrs C; Plass C
Mol Cell; 2014 Aug; 55(4):604-14. PubMed ID: 25087872
[TBL] [Abstract][Full Text] [Related]
4. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney.
O'Meara E; Stack D; Lee CH; Garvin AJ; Morris T; Argani P; Han JS; Karlsson J; Gisselson D; Leuschner I; Gessler M; Graf N; Fletcher JA; O'Sullivan MJ
J Pathol; 2012 May; 227(1):72-80. PubMed ID: 22294382
[TBL] [Abstract][Full Text] [Related]
6. Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney.
Karlsson J; Lilljebjörn H; Holmquist Mengelbier L; Valind A; Rissler M; Øra I; Fioretos T; Gisselsson D
Cancer Lett; 2015 Feb; 357(2):498-501. PubMed ID: 25481751
[TBL] [Abstract][Full Text] [Related]
7. Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression.
Karlsson J; Valind A; Jansson C; O'Sullivan MJ; Holmquist Mengelbier L; Gisselsson D
Oncotarget; 2016 Mar; 7(10):11127-36. PubMed ID: 26848979
[TBL] [Abstract][Full Text] [Related]
8. The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.
Gooskens SL; Kenny C; Lazaro A; O'Meara E; van Tinteren H; Spreafico F; Vujanic G; Leuschner I; Coulomb-L'Herminé A; Perotti D; de Camargo B; Bergeron C; Acha García T; Tanaka M; Pieters R; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM; O'Sullivan MJ
Genes Chromosomes Cancer; 2016 Feb; 55(2):143-7. PubMed ID: 26542179
[TBL] [Abstract][Full Text] [Related]
9. Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplication.
Santiago T; Clay MR; Azzato E; Newman S; Fernandez-Pineda I; Nichols KE; Zhang J; Downing JR; Davidoff A; Brennan RC; Ellison DW
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28440018
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma.
Ye YW; Jiang ZM; Li WH; Li ZS; Han YH; Sun L; Wang Y; Xie J; Liu YC; Zhao J; Tang AF; Li XX; Guan ZC; Gui YT; Cai ZM
Neoplasma; 2012; 59(6):599-605. PubMed ID: 22862160
[TBL] [Abstract][Full Text] [Related]
11. Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.
Kenny C; Bausenwein S; Lazaro A; Furtwängler R; Gooskens SL; van den Heuvel Eibrink M; Vokuhl C; Leuschner I; Graf N; Gessler M; O'Sullivan MJ
J Pathol; 2016 Apr; 238(5):617-20. PubMed ID: 27000436
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
[TBL] [Abstract][Full Text] [Related]
13. Novel Karyotypes and Cyclin D1 Immunoreactivity in Clear Cell Sarcoma of the Kidney.
Jet Aw S; Hong Kuick C; Hwee Yong M; Wen Quan Lian D; Wang S; Liang Loh AH; Ling S; Lian Peh G; Yen Soh S; Pheng Loh AH; Hoon Tan P; Tou En Chang K
Pediatr Dev Pathol; 2015; 18(4):297-304. PubMed ID: 25751590
[TBL] [Abstract][Full Text] [Related]
14. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways.
Cutcliffe C; Kersey D; Huang CC; Zeng Y; Walterhouse D; Perlman EJ;
Clin Cancer Res; 2005 Nov; 11(22):7986-94. PubMed ID: 16299227
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers.
Richards KL; Zhang B; Sun M; Dong W; Churchill J; Bachinski LL; Wilson CD; Baggerly KA; Yin G; Hayes DN; Wistuba II; Krahe R
Cancer; 2011 Feb; 117(3):606-17. PubMed ID: 20945327
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
Arab K; Smith LT; Gast A; Weichenhan D; Huang JP; Claus R; Hielscher T; Espinosa AV; Ringel MD; Morrison CD; Schadendorf D; Kumar R; Plass C
Carcinogenesis; 2011 Oct; 32(10):1467-73. PubMed ID: 21771727
[TBL] [Abstract][Full Text] [Related]
17. Genetic and genetic expression analyses of clear cell sarcoma of the kidney.
Schuster AE; Schneider DT; Fritsch MK; Grundy P; Perlman EJ
Lab Invest; 2003 Sep; 83(9):1293-9. PubMed ID: 13679437
[TBL] [Abstract][Full Text] [Related]
18. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion.
Wong MK; Ng CCY; Kuick CH; Aw SJ; Rajasegaran V; Lim JQ; Sudhanshi J; Loh E; Yin M; Ma J; Zhang Z; Iyer P; Loh AHP; Lian DWQ; Wang S; Goh SGH; Lim TH; Lim AST; Ng T; Goytain A; Loh AHL; Tan PH; Teh BT; Chang KTE
Histopathology; 2018 Jan; 72(2):320-329. PubMed ID: 28833375
[TBL] [Abstract][Full Text] [Related]
19. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney.
Mirkovic J; Calicchio M; Fletcher CD; Perez-Atayde AR
Histopathology; 2015 Sep; 67(3):306-12. PubMed ID: 25556515
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated mitogen-activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney.
Kenny C; McDonagh N; Lazaro A; O'Meara E; Klinger R; O'Connor D; Roche F; Hokamp K; O'Sullivan MJ
J Pathol; 2018 Mar; 244(3):334-345. PubMed ID: 29243812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
